Cart
sales@molnova.com
Trapencaine
CAS No. 76629-91-9
Trapencaine( —— )
Catalog No. M36243 CAS No. 76629-91-9
Trapencaine is a newly synthesized carbamate type local anesthetic that induces conformational changes in sodium channels on hypertrophic cell membranes.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 202 | Get Quote |
|
| 5MG | 304 | Get Quote |
|
| 10MG | 447 | Get Quote |
|
| 25MG | 710 | Get Quote |
|
| 50MG | 994 | Get Quote |
|
| 100MG | 1314 | Get Quote |
|
| 500MG | 2628 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTrapencaine
-
NoteResearch use only, not for human use.
-
Brief DescriptionTrapencaine is a newly synthesized carbamate type local anesthetic that induces conformational changes in sodium channels on hypertrophic cell membranes.
-
DescriptionTrapencaine is a newly synthesized carbamate type local anesthetic that induces conformational changes in sodium channels on hypertrophic cell membranes.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorSodium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number76629-91-9
-
Formula Weight374.52
-
Molecular FormulaC22H34N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO(C(NC1=CC(OCCCCC)=CC=C1)=O)C2C(CCCC2)N3CCCC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
BI-9627
BI-9627 is a selective and potent sodium hydrogen exchange isomer 1 (NHE1) inhibitor.BI-9627 partially reverses the effects of DMA with IC50 values of 6 and 31 nM in the intracellular pH recovery (pHi) and human platelet lysis assays.
-
Suzetrigine
Suzetrigine（VX-548） is an orally active and specific NaV1.8 inhibitor. Suzetrigine has analgesic activity and can be used to study acute pain and neurotransmission.
-
Lacosamide
An anticonvulsant compound that enhances the slow inactivation of voltage-gated sodium channels without affecting the fast inactivation of voltage-gated sodium channels.
